Search results
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 3 days agoARQT is a late-stage biopharmaceutical company. ARQT is focused on developing and commercializing ...
How to Get Rid of Redness on Face
Time Magazine· 6 days agoGerms, bacteria, temperature fluctuations, harsh weather, and irritants are some of things your skin protects you from. Figuring out the true cause of...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 6 days agoSolid sales of Dupixent (approved for use in certain patients with atopic dermatitis, asthma,...
239 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Ables Iannone Moore & Associates Inc.
ETF DAILY NEWS· 6 days agoAbles Iannone Moore & Associates Inc. bought a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Canandaigua National Bank & Trust Co. Trims Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoCanandaigua National Bank & Trust Co. reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% in the 1st quarter, according to the company in its most recent 13F filing ...
Modus Advisors LLC Acquires 450 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoModus Advisors LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities ...
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
TipRanks via Yahoo Finance· 3 days agoRegeneron (NASDAQ:REGN) stock has more than tripled in value in the past five years, with the price...
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 6 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 6 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga reports. Piper ...
M&R Capital Management Inc. Has $2.84 Million Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoM&R Capital Management Inc. reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 1st quarter, according to the company in its most recent filing with the Securities ...